Successful engraftment but high viral reactivation after reduced intensity unrelated umbilical cord blood transplantation for sickle cell disease

      Introduction: HLA-matched sibling donor (MSD) hematopoietic stem cell transplant is curative in >92% of patients with sickle cell disease (SCD) but only 18% have MSD. Unrelated cord blood transplantation (UCBT) expands donor options but is associated with high graft rejection rates (50–62%). We hypothesized that a previously used reduced intensity conditioning (RIC) regimen when combined with thiotepa would have acceptable toxicity and support donor engraftment after UCBT for SCD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect